On 14 November 2025, EPS Creative Health Technology Group Limited (3860) issued a notice that its board of directors plans to convene on 27 November 2025. The agenda includes reviewing and approving the unaudited interim results for the six-month period ended 30 September 2025, as well as considering a potential interim dividend.
The board, comprising executive, non-executive, and independent non-executive directors, will formally assess the company’s performance and dividend distribution based on the latest financial data. Any decisions regarding dividend payment will be disclosed following the board meeting.